Ilia A Toshkov Selected Research

CBLB502

12/2021	A deimmunized and pharmacologically optimized Toll-like receptor 5 agonist for therapeutic applications.
1/2017	Mitigation of Radiation-Induced Epithelial Damage by the TLR5 Agonist Entolimod in a Mouse Model of Fractionated Head and Neck Irradiation.
1/2015	The Toll-Like Receptor 5 Agonist Entolimod Mitigates Lethal Acute Radiation Syndrome in Non-Human Primates.
2/2014	Toll-like receptor-5 agonist Entolimod broadens the therapeutic window of 5-fluorouracil by reducing its toxicity to normal tissues in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ilia A Toshkov Research Topics

Disease

4	Neoplasms (Cancer) 12/2021 - 04/2004
2	Infections 03/2007 - 11/2004
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2017
1	Acute Radiation Syndrome 01/2015
1	Anemia 01/2015
1	Neutropenia 01/2015
1	Thrombocytopenia (Thrombopenia) 01/2015
1	Colonic Neoplasms (Colon Cancer) 02/2014
1	Viremia 03/2007
1	Hepatitis B 11/2004
1	Adenoma (Adenomas) 04/2004
1	Hepatocellular Carcinoma (Hepatoma) 04/2004

Drug/Important Bio-Agent (IBA)

4	CBLB502IBA 12/2021 - 02/2014
3	Toll-Like Receptor 5IBA 12/2021 - 01/2015
3	DNA (Deoxyribonucleic Acid)IBA 02/2014 - 04/2004
2	FlagellinIBA 12/2021 - 01/2017
1	Fluorouracil (Carac)FDA LinkGeneric 02/2014
1	Surface Antigens (Surface Antigen)IBA 03/2007
1	AntibodiesIBA 03/2007
1	Antiviral Agents (Antivirals)IBA 11/2004
1	NucleosidesIBA 11/2004

Therapy/Procedure

1	Immunotherapy 12/2021
1	Radiotherapy 01/2017
1	Therapeutics 11/2004